• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

What Is the Role of Long-Term Macrolide Therapy in the Treatment of Recalcitrant Chronic Rhinosinusitis?

by Zachary M. Soler, MD, and Timothy l. Smith, MD, MPH • October 2, 2012

  • Tweet
  • Email
Print-Friendly Version

Trio Best PracticeBackground

Long-duration therapy with macrolide antibiotics has been advocated for the treatment of recalcitrant chronic rhinosinusitis (CRS). The rationale for this treatment is based on the unique anti-inflammatory properties of macrolides rather than a strict antibacterial effect. However, uncertainty exists as to which patients will respond to such treatment, the degree of benefit likely to be obtained and the relevant risks to the patient and community at large.

You Might Also Like

  • What Is the Role of Nasal Endoscopy in the Diagnosis of Chronic Rhinosinusitis?
  • Is Topical Amphotericin B Efficacious in the Treatment of Chronic Rhinosinusitis?
  • Integrated Approach Key to Evaluating Recalcitrant Rhinosinusitis Patients
  • What Is the Role of the Adenoid in Pediatric Chronic Rhinosinusitis?
Explore This Issue
October 2012

Best Practice

Low-dose, long-duration macrolide therapy is a viable option for patients with CRS refractory to standard medical and surgical therapies. Based on the limited evidence available, daily clarithromycin (250 mg), azithromycin (250 mg) or roxithromycin (150 mg) should be continued for at least 12 weeks to achieve measurable results. Patients should be selected carefully, as those with atopy and eosinophilic inflammation are unlikely to respond. Patients should understand that improvements are likely to be modest, and symptoms will likely not be fully controlled. At this point in time, further studies are needed to determine whether treatment longer than 12 weeks is beneficial. Similarly, future studies are needed to document the long-term outcomes after cessation of therapy. Available evidence suggests that low-dose macrolide therapy is safe for the individual patient, but clinicians should remain cognizant of the potential for bacterial resistance in the population at large. Read the full article in The Laryngoscope.

Filed Under: Departments, Medical Education, Practice Focus, Rhinology, TRIO Best Practices Tagged With: antibiotics, macrolide antibiotics, rhinology, rhinosinusitis, SinusitisIssue: October 2012

You Might Also Like:

  • What Is the Role of Nasal Endoscopy in the Diagnosis of Chronic Rhinosinusitis?
  • Is Topical Amphotericin B Efficacious in the Treatment of Chronic Rhinosinusitis?
  • Integrated Approach Key to Evaluating Recalcitrant Rhinosinusitis Patients
  • What Is the Role of the Adenoid in Pediatric Chronic Rhinosinusitis?

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Have you invented or patented something that betters the field of otolaryngology?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • The Best Site for Pediatric TT Placement: OR or Office?

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Keeping Watch for Skin Cancers on the Head and Neck

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • Leaky Pipes—Time to Focus on Our Foundations
    • You Are Among Friends: The Value Of Being In A Group
    • How To: Full Endoscopic Procedures of Total Parotidectomy
    • How To: Does Intralesional Steroid Injection Effectively Mitigate Vocal Fold Scarring in a Rabbit Model?
    • What Is the Optimal Anticoagulation in HGNS Surgery in Patients with High-Risk Cardiac Comorbidities?

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939